The crucial role of androgen receptor (AR) in prostate cancer development is well documented, and its inhibition is a mainstay of prostate cancer treatment. Here, we analyze the perturbations to the AR cistrome caused by a minor groove binding molecule that is designed to target a sequence found in a subset of androgen response elements (ARE). We find treatment with this pyrrole-imidazole (Py-Im) polyamide exhibits sequence selectivity in its repression of AR binding in vivo. Differentially changed loci are enriched for sequences resembling ARE half-sites that match the Py-Im polyamide binding preferences determined in vitro. Comparatively, permutations of the ARE half-site bearing single or double mismatches to the Py-Im polyamide binding ...
Copyright © 2006 by The Endocrine SocietyThere is increasing evidence that sensitization of the andr...
Many cancer therapeutics target DNA and exert cytotoxicity through the induction of DNA damage and i...
Around 80-90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence,...
The crucial role of androgen receptor (AR) in prostate cancer development is well documented, and it...
The LREX' prostate cancer model is resistant to the antiandrogen enzalutamide via activation of an a...
The antiproliferative effects of Py-Im polyamides have been evaluated in several cancer models. The ...
Pyrrole-imidazole (Py-Im) polyamides are high affinity DNA-binding small molecules that can inhibit ...
Prostate cancer is the second leading cause of death from cancer among males in Western countries. I...
Pyrrole–Imidazole polyamides are programmable, cell-permeable small molecules that bind in the minor...
Pyrrole-imidazole (Py-Im) polyamides are high affinity DNA-binding small molecules that can inhibit ...
Pyrrole-imidazole (Py–Im) polyamides are a class of programmable DNA minor groove binders capable of...
Recurrent, metastatic prostate cancer continues to be a leading cause of cancer-death in men. The a...
The human androgen receptor (AR) is considered as a master regulator in the development and progress...
The androgen receptor (AR) is a member of the steroid receptor superfamily that regulates gene expre...
Androgen receptor (AR), an important target in the current androgen derivation therapy, plays a crit...
Copyright © 2006 by The Endocrine SocietyThere is increasing evidence that sensitization of the andr...
Many cancer therapeutics target DNA and exert cytotoxicity through the induction of DNA damage and i...
Around 80-90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence,...
The crucial role of androgen receptor (AR) in prostate cancer development is well documented, and it...
The LREX' prostate cancer model is resistant to the antiandrogen enzalutamide via activation of an a...
The antiproliferative effects of Py-Im polyamides have been evaluated in several cancer models. The ...
Pyrrole-imidazole (Py-Im) polyamides are high affinity DNA-binding small molecules that can inhibit ...
Prostate cancer is the second leading cause of death from cancer among males in Western countries. I...
Pyrrole–Imidazole polyamides are programmable, cell-permeable small molecules that bind in the minor...
Pyrrole-imidazole (Py-Im) polyamides are high affinity DNA-binding small molecules that can inhibit ...
Pyrrole-imidazole (Py–Im) polyamides are a class of programmable DNA minor groove binders capable of...
Recurrent, metastatic prostate cancer continues to be a leading cause of cancer-death in men. The a...
The human androgen receptor (AR) is considered as a master regulator in the development and progress...
The androgen receptor (AR) is a member of the steroid receptor superfamily that regulates gene expre...
Androgen receptor (AR), an important target in the current androgen derivation therapy, plays a crit...
Copyright © 2006 by The Endocrine SocietyThere is increasing evidence that sensitization of the andr...
Many cancer therapeutics target DNA and exert cytotoxicity through the induction of DNA damage and i...
Around 80-90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence,...